4SC

Planegg, Bavaria, Germany

+490897007630 ★

http://www.4sc.de/

Company profile

4SC company profile

4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.

Business identity

Website: http://www.4sc.de/
Contact email: [email protected]
Phone number: +490897007630
Operating status: Active
Company type: For Profit
Employee range: 00051-00100 employees
Revenue range: $0+
Founded: 1997-01-01

LinkedIn Facebook X

Headquarters

Headquarters: Planegg, Bavaria, Germany
Postal code: 82152
Country code: DE
Continent: Europe

Capital profile

Funding and company signals

Funding stage: Ipo
Funding rounds: 8
Total equity funding: $97.8M
Last funding: Post Ipo Equity / $24.7M / 2019-11-12
Last equity funding: Post Ipo Equity / $24.7M
Investors: 9
Lead investors: 2
Articles: 11
Exited on: 2005-12-15

Categories and groups

Biopharma Biotechnology Therapeutics Biotechnology Health Care Science and Engineering

Founders and investors

Lead investors

3i GroupDeutsche Venture Capital

Investors

3i GroupBayern KapitalBionX™ Medical TechnologiesSanto HoldingWellington Partners

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.